All Relations between dopaminergic and neurotransmitter

Publication Sentence Publish Date Extraction Date Species
Anne Saulin, Markus Savli, Rupert Lanzenberge. Serotonin and molecular neuroimaging in humans using PET. Amino acids. vol 42. issue 6. 2012-09-10. PMID:21947614. along with the dopaminergic system, it is also one of the phylogenetically oldest human neurotransmitter systems and one of the most diverse, with 14 different receptors identified up to this day, many of whose function remains to be understood. 2012-09-10 2023-08-12 human
Manfred Ackenheil, Klaus Webe. Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects. Dialogues in clinical neuroscience. vol 6. issue 1. 2012-09-10. PMID:22034253. a combined analysis of genetic polymorphisms in the dopaminergic and serotonergic receptors, neurotransmitter transporters, and other target structures involved in psychiatric disorders is already a powerful predictor of therapeutic outcome. 2012-09-10 2023-08-12 Not clear
Marjolein B Aerts, Rianne A J Esselink, Jugen A H R Claassen, Wilson Farid Abdo, Bastiaan R Bloem, Marcel M Verbee. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease. Journal of Alzheimer's disease : JAD. vol 27. issue 2. 2012-08-16. PMID:21841257. since deficits in serotonergic and dopaminergic pathways seem more pronounced in dlb patients, we investigated whether cerebrospinal fluid (csf) analysis of neurotransmitter metabolites, in addition to brain-specific proteins, may improve the differentiation between dlb and ad. 2012-08-16 2023-08-12 Not clear
Toru Baba, Atsushi Taked. [Recent advances in imaging in Parkinson disease]. Brain and nerve = Shinkei kenkyu no shinpo. vol 64. issue 4. 2012-06-21. PMID:22481515. moreover, radiotracer imaging with dopaminergic markers facilitates the assessment of pre- and postsynaptic nigro-striatal integrity, and other radiotracers have been used in the studies of nondopaminergic neurotransmitter systems, such as the cholinergic, noradrenergic, and serotonergic systems. 2012-06-21 2023-08-12 Not clear
Kenneth Blum, Eliot Gardner, Marlene Oscar-Berman, Mark Gol. "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Current pharmaceutical design. vol 18. issue 1. 2012-05-31. PMID:22236117. elevated stress levels, together with polymorphisms of dopaminergic genes and other neurotransmitter genetic variants, may have a cumulative effect on vulnerability to addiction. 2012-05-31 2023-08-12 Not clear
Saül Martínez-Horta, Jaime Kulisevsk. Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"? Journal of neural transmission (Vienna, Austria : 1996). vol 118. issue 8. 2012-05-29. PMID:21695418. while fronto-striatal defects appear more related to dopaminergic defects, posterior-cortical defects may obey multiple neurotransmitter failure. 2012-05-29 2023-08-12 Not clear
S Josefin Dahlbom, Tobias Backström, Katrin Lundstedt-Enkel, Svante Winber. Aggression and monoamines: effects of sex and social rank in zebrafish (Danio rerio). Behavioural brain research. vol 228. issue 2. 2012-05-23. PMID:22192379. in addition, effects on the brain serotonergic and dopaminergic neurotransmitter systems after agonistic interaction are well studied in many species, but not in zebrafish. 2012-05-23 2023-08-12 zebrafish
b' Ljiljana Jaukovi\\xc4\\x87, Tihomir V Ili\\xc4\\x87, Marija Dopudja, Boris Ajdinovi\\xc4\\x8. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results. Vojnosanitetski pregled. vol 69. issue 2. 2012-05-15. PMID:22500370.' 123i-fp-cit brain single-photon emission computed tomography (spect), datscan imaging, offers a possibility to study structural and biochemical integrity of presinaptic dopaminergic neurotransmitter system. 2012-05-15 2023-08-12 Not clear
E P Rico, D B Rosemberg, K J Seibt, K M Capiotti, R S Da Silva, C D Bona. Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets. Neurotoxicology and teratology. vol 33. issue 6. 2012-05-14. PMID:21907791. here, we present a review regarding the role of different excitatory and inhibitory neurotransmitter systems in zebrafish, such as dopaminergic, serotoninergic, cholinergic, purinergic, histaminergic, nitrergic, glutamatergic, glycinergic, and gabaergic systems, and emphasizing their features as pharmacological and toxicological targets. 2012-05-14 2023-08-12 zebrafish
Rajesh S Yadav, Lalit P Chandravanshi, Rajendra K Shukla, Madhu L Sankhwar, Reyaz W Ansari, Pradeep K Shukla, Aditya B Pant, Vinay K Khann. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology. vol 32. issue 6. 2012-05-02. PMID:21839772. our recent studies have shown that curcumin protects arsenic induced neurotoxicity by modulating oxidative stress, neurotransmitter levels and dopaminergic system in rats. 2012-05-02 2023-08-12 rat
Lydia M Mexas, Virginia R Florang, Jonathan A Door. Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. Neurotoxicology. vol 32. issue 4. 2012-04-23. PMID:21514317. parkinson's disease (pd) is a neurodegenerative disorder marked by the selective loss of dopaminergic neurons, leading to a decrease of the neurotransmitter dopamine (da). 2012-04-23 2023-08-12 Not clear
Laura Hondebrink, Jan Meulenbelt, Marieke Meijer, Martin van den Berg, Remco H S Westerin. High concentrations of MDMA ('ecstasy') and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells. Neuropharmacology. vol 61. issue 1-2. 2012-04-17. PMID:21497613. our data suggest that the dat-independent increase in extracellular da in vivo is not due to direct stimulation of exocytosis, but rather to effects of these drugs on other neurotransmitter systems that innervate the dopaminergic system. 2012-04-17 2023-08-12 Not clear
Jussi Hirvonen, Jarmo Hietala, Jaana Kajander, Juha Markkula, Helena Rasi-Hakala, Jouko K Salminen, Kjell Någren, Sargo Aalto, Hasse Karlsso. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET. Journal of psychopharmacology (Oxford, England). vol 25. issue 10. 2012-04-06. PMID:20829308. antidepressant drug treatment and psychotherapy are both effective in treating major depression, but there are no published studies comparing the effects of these two treatments on the dopaminergic neurotransmitter system in major depression. 2012-04-06 2023-08-12 Not clear
R Maldonado, F Berrendero, A Ozaita, P Robled. Neurochemical basis of cannabis addiction. Neuroscience. vol 181. 2012-03-16. PMID:21334423. several neurotransmitter systems involved in the addictive effects of other prototypical drugs of abuse, such as the dopaminergic and the opioid system are also involved in cannabis addiction. 2012-03-16 2023-08-12 Not clear
Agnieszka Permoda-Osip, Janusz Rybakowsk. [Glutamatergic conception of mood disorders]. Psychiatria polska. vol 45. issue 6. 2012-03-06. PMID:22335130. the neurotransmitter theories of the pathogenesis and treatment of mood disorders presented so far focused mainly on serotonergic and catecholaminergic (noradrenergic and dopaminergic) transmission. 2012-03-06 2023-08-12 Not clear
Daniel Collerton, Elaine Perr. Dreaming and hallucinations - continuity or discontinuity? Perspectives from dementia with Lewy bodies. Consciousness and cognition. vol 20. issue 4. 2012-02-24. PMID:21531149. variations in cholinergic, dopaminergic and serotonergic neurotransmitter function during sleep and during hallucinations in lewy body dementias, together with relevant drug effects suggest that, on the whole, different, potentially opposite, changes characterise the two states. 2012-02-24 2023-08-12 Not clear
Maria Trinidad Herrero, Javier Pagonabarraga, Gurutz Linazasor. Neuroprotective role of dopamine agonists: evidence from animal models and clinical studies. The neurologist. vol 17. issue 6 Suppl 1. 2012-02-21. PMID:22045327. parkinson disease is a progressive neurodegenerative disease that affects, among other neurotransmitter systems, the nigrostriatal dopaminergic projection. 2012-02-21 2023-08-12 Not clear
Nicole A Datson, Niels Speksnijder, Inge E M de Jong, Peter J Steenbergen, Kenneth Vielsted Christensen, Krzysztof Potempa, Jan Torleif Pedersen, Jan Egebjerg, Pekka Kallunki, Erik B Nielsen, E Ronald de Kloet, Michael Didrikse. Hippocampal CA1 region shows differential regulation of gene expression in mice displaying extremes in behavioral sensitization to amphetamine: relevance for psychosis susceptibility? Psychopharmacology. vol 217. issue 4. 2012-02-13. PMID:21537941. psychosis susceptibility is mediated in part by the dopaminergic neurotransmitter system. 2012-02-13 2023-08-12 mouse
Katharina M Iwaniuk, Jessica Schira, Sandra Weinhold, Marc Jung, James Adjaye, Hans Werner Müller, Peter Wernet, Hans-Ingo Trompete. Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood. Stem cells and development. vol 20. issue 8. 2012-01-27. PMID:21067317. they show differentiation into neuronal cells of a dopaminergic phenotype, which express neuronal markers such as synaptophysin, neuronal-specific nuclear protein, and neurofilament and release the neurotransmitter dopamine accompanied by expression of dopaminergic key factors tyrosine hydroxylase and nurr1 (nr4a2). 2012-01-27 2023-08-12 human
Noriaki Koshikawa, Satoshi Fujita, Kazunori Adach. Behavioral pharmacology of orofacial movement disorders. International review of neurobiology. vol 97. 2011-10-25. PMID:21708305. regarding neurotransmitter systems, dopaminergic, cholinergic, γ-aminobutyric acid (gaba)ergic and glutamaterigic systems have been shown to be involved in rat rhythmical jaw movements. 2011-10-25 2023-08-12 rat